Direkt zum Inhalt
Merck

Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2009-01-09)
Qi Chen, Charles A Peto, G Diane Shelton, Andrew Mizisin, Paul E Sawchenko, David Schubert
ZUSAMMENFASSUNG

Axonal dysfunction is the major phenotypic change in many neurodegenerative diseases, but the processes underlying this impairment are not clear. Modifier of cell adhesion (MOCA) is a presenilin binding protein that functions as a guanine nucleotide exchange factor for Rac1. The loss of MOCA in mice leads to axonal degeneration and causes sensorimotor impairments by decreasing cofilin phosphorylation and altering its upstream signaling partners LIM kinase and p21-activated kinase, an enzyme directly downstream of Rac1. The dystrophic axons found in MOCA-deficient mice are associated with abnormal aggregates of neurofilament protein, the disorganization of the axonal cytoskeleton, and the accumulation of autophagic vacuoles and polyubiquitinated proteins. Furthermore, MOCA deficiency causes an alteration in the actin cytoskeleton and the formation of cofilin-containing rod-like structures. The dystrophic axons show functional abnormalities, including impaired axonal transport. These findings demonstrate that MOCA is required for maintaining the functional integrity of axons and define a model for the steps leading to axonal degeneration.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-APP-A4-Antikörper, a.a. 66-81 von APP {NT}, Klon 22C11, clone 22C11, Chemicon®, from mouse
Sigma-Aldrich
Propylgallat, powder
Sigma-Aldrich
Propylgallat, ≥98%, FCC
Sigma-Aldrich
Propylgallat, for microscopy, ≥98.0% (HPLC)
Sigma-Aldrich
Anti-Cholinacetyltransferase (ChAT)-Antikörper, serum, Chemicon®
Supelco
Propylgallat, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Propylgallat, antioxidant, ≥98.0% (HPLC)